MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Glaukos Corp Company Profile (NYSE:GKOS)

Consensus Ratings for Glaukos Corp (NYSE:GKOS) (?)
Ratings Breakdown: 2 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $32.00 (13.60% upside)

Analysts' Ratings History for Glaukos Corp (NYSE:GKOS)
Show:
DateFirmActionRatingPrice TargetActions
6/2/2016Cantor FitzgeraldInitiated CoverageNot Available -> Buy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Piper JaffrayReiterated RatingOverweight$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Roth CapitalBoost Price TargetBuy$24.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016JPMorgan Chase & Co.Lower Price TargetOverweight$32.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Goldman SachsLower Price Target$33.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Bank of AmericaInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Canaccord GenuityInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Glaukos Corp (NYSE:GKOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/10/2016        
5/3/2016Q116($0.15)$0.03$18.77 million$23.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q415($0.13)($0.07)$20.07 million$20.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q315($0.17)($0.07)$17.93 million$19.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Glaukos Corp (NYSE:GKOS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Glaukos Corp (NYSE:GKOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Glaukos Corp (NYSE:GKOS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/20/2016Richard L HarrisonCFOSell4,300$30.00$129,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Thomas William BurnsCEOSell7,997$30.00$239,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Chris M CalcaterraInsiderSell45,464$28.46$1,293,905.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Thomas William BurnsCEOSell24,578$25.16$618,382.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Thomas William BurnsCEOSell422$25.00$10,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Thomas William BurnsCEOSell25,000$23.90$597,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Thomas William BurnsCEOSell300$25.00$7,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Chris M CalcaterraInsiderSell74,536$24.40$1,818,678.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Richard L HarrisonCFOSell30,000$24.59$737,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Thomas William BurnsCEOSell36,700$24.67$905,389.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Aimee S WeisnerDirectorBuy2,500$16.03$40,075.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Montreux Equity Partners Iv LpMajor ShareholderSell70,000$16.16$1,131,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Richard L HarrisonCFOBuy1,388$15.30$21,236.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Aimee S WeisnerDirectorBuy2,500$21.83$54,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Glaukos Corp (NYSE:GKOS)
DateHeadline
06/20/16 04:03 PMThis Weeks Broker Views For Glaukos Corporation (NYSE:GKOS) - Fiscal Standard
06/20/16 01:29 PMETF’s with exposure to Glaukos Corp. : June 20, 2016 -
06/20/16 07:43 AM3 Reasons Why Glaukos (GKOS) is a Great Momentum Stock -
06/16/16 08:35 AMShares of Glaukos Corporation (NYSE:GKOS) Sees Large Outflow of Money - Trade Calls
06/14/16 07:16 AMMoving Average Crossover Alert: Glaukos (GKOS) -
06/06/16 07:02 AMGLAUKOS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/05/16 04:07 PMGlaukos Corp (GKOS) Receives Buy Rating from Piper Jaffray - Let Me Know About This
06/04/16 04:40 AMSizzling Healthcare Stocks Update: Glaukos Corporation (NYSE:GKOS) , C.R. Bard, Inc. (NYSE:BCR) - Is stories
06/04/16 04:40 AMGlaukos Corp (GKOS) CEO Thomas William Burns Sells 422 Shares - Let Me Know About This
06/03/16 04:31 PMGlaukos Corporation Common Stoc (NYSE:GKOS) Trading Up – Insiders Selling, Short Interest Growing
06/03/16 03:03 PMGLAUKOS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 09:38 AMCantor Fitzgerald Assumes Coverage Of Glaukos Corp With Buy, $35TP - Cantor Fitzgerald has assumed coverage of Glaukos Corp (NYSE: GKOS) with a Buy rating and $35 price target on the market potential for its iStent device in Glaucoma treatment. "Through innovation, we believe the company can not only maintain but likely expand its leading position," analyst Elemer Piros wrote in a note. The analyst estimates, in its third year on the market, iStent was used in over 70,000 procedures in 2015. iStent sales is expected to grow on its established trajectory ($100 million in sales expected in 2016). The Laguna Hills, California-based company is ...Full story available on Benzinga.com
06/03/16 04:48 AM25000 Shares of Stock are sold by Insider Selling: Glaukos Corp (GKOS) CEO - Let Me Know About This - Share Trading News25000 Shares of Stock are sold by Insider Selling: Glaukos Corp (GKOS) CEOLet Me Know About ThisGlaukos Corp logo Glaukos Corp (NYSE:GKOS) CEO Thomas William Burns sold 25,000 shares of Glaukos Corp stock in a transaction dated Wednesday, June 1st. The shares were sold at an average price of $23.90, for a total transaction of $597,500.00.Glaukos Corp (GKOS) Now Covered by Cantor FitzgeraldCommunity Financial NewsGlaukos Corporation (NYSE:GKOS) Issued With 'Buy' Rating From Cantor FitzgeraldShare Trading NewsGlaukos Corporation Common Stoc (NYSE:GKOS) Trading Up - Insiders Selling, Short Interest GrowingFinance DailyMarkets.coall 7 news articles »
06/02/16 10:26 PMCantor Fitzgerald Initiates Coverage on Glaukos Corp (GKOS) - Let Me Know About This - Share Trading NewsCantor Fitzgerald Initiates Coverage on Glaukos Corp (GKOS)Let Me Know About ThisGlaukos Corp logo Investment analysts at Cantor Fitzgerald assumed coverage on shares of Glaukos Corp (NYSE:GKOS) in a research note issued to investors on Thursday. The firm set a “buy” rating and a $35.00 price target on the stock. Cantor Fitzgerald ...Glaukos Corporation (NYSE:GKOS) Sellers Covered 6.46% of Their ShortsThe PostGlaukos Corporation (NYSE:GKOS) Issued With 'Buy' Rating From Cantor FitzgeraldShare Trading NewsGlaukos Corporation Common Stoc (NYSE:GKOS) Trading Up - Insiders Selling, Short Interest GrowingFinance Dailyall 7 news articles »
06/01/16 03:45 PMGlaukos Announces Participation in Upcoming Investor Conferences - [at noodls] - LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures ...
06/01/16 04:58 AMTarget Price and Stock Performance Rundown for Glaukos Corp (NYSE:GKOS) - HNN - Target Price and Stock Performance Rundown for Glaukos Corp (NYSE:GKOS)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Glaukos Corp (NYSE:GKOS) shares ...and more »
05/30/16 09:45 PMStock Review and Earnings Check on Glaukos Corp (NYSE:GKOS) - HNN - Stock Review and Earnings Check on Glaukos Corp (NYSE:GKOS)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Glaukos Corp (NYSE:GKOS) to ...and more »
05/29/16 10:34 AMGlaukos Corporation (NYSE:GKOS) Shorted Shares Decreased By 6.46% - HNN - Glaukos Corporation (NYSE:GKOS) Shorted Shares Decreased By 6.46%HNNThe stock of Glaukos Corporation (NYSE:GKOS) registered a decrease of 6.46% in short interest. GKOS's total short interest was 854,300 shares in May as published by FINRA. Its down 6.46% from 913,300 shares, reported previously. With 618,800 shares ...Is it Time to Cash in Profits on Glaukos Corporation (NYSE:GKOS)Franklin Independentall 2 news articles »
05/26/16 05:19 AMGlaukos Corp (NYSE:GKOS) Quarterly EPS From Continuing Operations Stands At $0.0278 - Investor Newswire - Glaukos Corp (NYSE:GKOS) Quarterly EPS From Continuing Operations Stands At $0.0278Investor NewswireGlaukos Corp (NYSE:GKOS) diluted EPS from parent firm came at $-2.1312 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it came at $-2.1312. Glaukos Corp (NYSE:GKOS) posted net basic EPS of $-2.13 for the year ended 2016-03-31.and more »
05/24/16 01:13 PMEarnings Review and Stock Rundown for Glaukos Corp (NYSE:GKOS) - Wall Street Hints and News - Earnings Review and Stock Rundown for Glaukos Corp (NYSE:GKOS)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Glaukos Corp (NYSE:GKOS) to post ...and more »
05/23/16 01:33 PMTarget Check and Stock Performance Recap Glaukos Corp (NYSE:GKOS) - Wall Street Hints and News - Target Check and Stock Performance Recap Glaukos Corp (NYSE:GKOS)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Glaukos Corp (NYSE:GKOS) ...and more »
05/20/16 01:45 PMStatistics Don't Lie: Glaukos Corp (NYSE:GKOS) Earnings Preview - Street Register - Statistics Don't Lie: Glaukos Corp (NYSE:GKOS) Earnings PreviewStreet RegisterGlaukos Corporation (GKOS) retreated -1.2% to reach at the floor price of $23.91 as the company is set to share its next quarterly earnings on August 10, 2016. GKOS stock trades between $23.63 and $24.38 before the earnings release. Let's take a closer ...
05/20/16 01:45 PMRevenue Update on Glaukos Corp(NYSE:GKOS) - Trade Calls - Revenue Update on Glaukos Corp(NYSE:GKOS)Trade CallsGlaukos Corp(NYSE:GKOS) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 3, 2016. Company reported revenue of $23.09M. Analysts estimated a revenue of $18.77M. Earnings per share were ...Glaukos Corporation (NYSE:GKOS) Shorted Shares Decreased By 5.12%Franklin Independentall 2 news articles »
05/20/16 06:58 AMCan Glaukos Corporation (GKOS) Keep the Earnings Streak Alive This Quarter? -
05/19/16 01:56 PMBaron Funds Comments on Glaukos Corporation - Shares of Glaukos Corporation (NYSE:GKOS) declined in the first quarter as a result of the massive correction in the biotech/pharma space. Glaukos, which manufactures stents to relieve glaucoma pressure, expects 26% to 30% growth in 2016, which we think ...
05/17/16 01:48 PMStock Update and Earnings Review for Glaukos Corp (NYSE:GKOS) - Wall Street Hints and News - Stock Update and Earnings Review for Glaukos Corp (NYSE:GKOS)Wall Street Hints and NewsCompany earnings numbers are typically highly analyzed by investors and analysts alike. Earnings are important because they can provide insight into a company's profitability. Sell-side Street analysts are expecting Glaukos Corp (NYSE:GKOS) to post ...and more »
05/17/16 01:48 PMShare Recap and Earnings Focus on Glaukos Corp (NYSE:GKOS) - Wall Street Hints and News - Share Recap and Earnings Focus on Glaukos Corp (NYSE:GKOS)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Glaukos Corp (NYSE:GKOS) ...and more »
05/16/16 05:45 PMETF’s with exposure to Glaukos Corp. : May 16, 2016 -
05/16/16 06:32 AMCan The Uptrend Continue for Glaukos (GKOS)? -
05/13/16 09:36 AMGlaukos Corp. :GKOS-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/12/16 12:04 PMGLAUKOS CORP Financials -
05/12/16 07:43 AMWhy Glaukos Corporation (GKOS) Could Be an Impressive Growth Stock -
05/11/16 12:59 PMStock Update and Earnings Review for Glaukos Corp (NYSE:GKOS) - B.O.D.Y Confidential - Stock Update and Earnings Review for Glaukos Corp (NYSE:GKOS)B.O.D.Y ConfidentialCompany earnings numbers are typically highly analyzed by investors and analysts alike. Earnings are important because they can provide insight into a company's profitability. Sell-side Street analysts are expecting Glaukos Corp (NYSE:GKOS) to post ...and more »
05/11/16 12:59 PMPerformance Recap and Target Perspective on Glaukos Corp (NYSE:GKOS) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Glaukos Corp (NYSE:GKOS)B.O.D.Y ConfidentialIn the latest trading session, shares of Glaukos Corp (NYSE:GKOS) moved +0.71%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/08/16 12:19 PMNext Weeks Broker Price Targets For Glaukos Corporation (NYSE:GKOS) - Share Trading News - Next Weeks Broker Price Targets For Glaukos Corporation (NYSE:GKOS)Share Trading News05/04/2016 – Glaukos Corporation had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 27 price target on the stock. 04/07/2016 – Stifel Nicolaus began new coverage on Glaukos Corporation giving the company a “hold” ...and more »
05/07/16 12:36 PMGlaukos Corp (GKOS) Surges on Strong Earnings, Improved Outlook - Glaukos Corp (NYSE:GKOS) stock is trading up over 25% today following upbeat quarterly results reported by the company last evening. The company managed to surpass both top and bottom line forecasts and also improved its previously provided full-year ...
05/07/16 12:36 PMToday Glaukos Corp Stock Crashes - Glaukos Corporation was founded in 1998 and is headquartered in Laguna Hills, California. Glaukos Corporation (GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures created ...
05/07/16 12:36 PMGlaukos Corporation (NYSE:GKOS) Shorts Decreased by 8.45% After Short Covering - Glaukos is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world's leading causes of blindness. Glaukos Corp (NYSE:GKOS ...
05/06/16 01:40 PM3 Stocks to Watch For: Glaukos Corporation (GKOS), Carnival Corporation (CCL), Companhia de Saneamento Basico ... - iStreetWire - 3 Stocks to Watch For: Glaukos Corporation (GKOS), Carnival Corporation (CCL), Companhia de Saneamento Basico ...iStreetWireGlaukos Corporation (GKOS) saw its value increase by 24.66% as the stock gained $4.9 to finish the day at a closing price of $24.77. The stock was lighter in trading and has fluctuated between $14.25-$33.92 per share for the past year. The shares ...and more »
05/05/16 01:21 PMInvestor's Watch on Overbuying: Glaukos Corp (NYSE:GKOS) - The Point Review - The Point ReviewInvestor's Watch on Overbuying: Glaukos Corp (NYSE:GKOS)The Point ReviewThe relative strength index (RSI), one of the most popular technical indicators, is computed on the basis of the speed and direction of a stock's price movement. The RSI value will always move between 0 and 100; the value will be 0 if the stock falls ...Glaukos Corp (GKOS) Surges on Strong Earnings, Improved OutlookBidness ETCGlaukos Corp. (GKOS) Surged After 2016 Guidance RaisedRTT NewsAverage EPS & Price Target Analysis: Glaukos Corp (NYSE:GKOS)News OracleVanguard Tribune -Franklin Independent -CWRU Observerall 29 news articles »
05/04/16 04:22 PMGLAUKOS CORP Files SEC form 10-Q, Quarterly Report -
05/04/16 01:01 PMWhy Glaukos Corp. Is Skyrocketing Today - An impressive earnings report filled with good news has traders bidding up shares on Wednesday.
05/04/16 12:34 PMEarnings Outlook on Glaukos Corp (NYSE:GKOS) - B.O.D.Y Confidential - Earnings Outlook on Glaukos Corp (NYSE:GKOS)B.O.D.Y ConfidentialAnalysts and investors will be anticipating Glaukos Corp (NYSE:GKOS)'s next earnings release which is expected to be posted on or around 2016-05-03. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.16 for the ...and more »
05/04/16 12:34 PMGlaukos Corp (GKOS) Surges on Strong Earnings, Improved Outlook - Bidness ETC - Bidness ETCGlaukos Corp (GKOS) Surges on Strong Earnings, Improved OutlookBidness ETCGlaukos Corp (NYSE:GKOS) stock is trading up over 25% today following upbeat quarterly results reported by the company last evening. The company managed to surpass both top and bottom line forecasts and also improved its previously provided full-year ...Glaukos Corp (GKOS) PT Raised to $30.00Web Breaking NewsStock's Earnings in Focus: Glaukos Corporation (GKOS)CWRU ObserverVersant Venture Management Lowers stake in Glaukos Corp (GKOS)Market DigestRisers & Fallers -Share Trading News -B.O.D.Y Confidentialall 17 news articles »
05/04/16 12:01 PMWhy Glaukos Corp is Skyrocketing Today -
05/04/16 06:10 AMGlaukos to Present at Bank of America Merrill Lynch 2016 Health Care Conference - [at noodls] - LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures ...
05/03/16 08:42 PMEdited Transcript of GKOS earnings conference call or presentation 3-May-16 8:30pm GMT -
05/03/16 03:32 PMGLAUKOS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
05/03/16 03:30 PMGlaukos Corporation Announces First Quarter 2016 Financial Results - [at noodls] - Company Raises 2016 Net Sales Guidance LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization ...
05/03/16 03:22 PM4:22 pm Glaukos beats by $0.18, beats on revs; guides FY16 revs above consensus -
About Glaukos Corp

Glaukos Corp logoGlaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring approximately one millimeter long and approximately 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a corneal incision. The Company's micro-scale injectable therapies include pipeline products, such as the iStent Inject, the iStent Supra and iDose. The iStent Inject includes approximately two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GKOS
  • CUSIP:
Key Metrics:
  • Previous Close: $28.17
  • 50 Day Moving Average: $25.84
  • 200 Day Moving Average: $20.58
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $915.89M
  • Current Quarter EPS Consensus Estimate: $-0.06 EPS
Additional Links:
Glaukos Corp (NYSE:GKOS) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha